IGF2BP3 and colorectal carcinoma: Moreover, the interrogation of the GEO dataset (GSE17536 and GSE17537) revealed that a higher level of IGF2BP3 was significantly associated with shorter overall survival in patients with CRC (Fig. 1f, g).